World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33519937

Number of visits today: 1367

Number of downloads: 16706310

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Goulding SR, Concannon RM, Morales-Prieto N, Villalobos-Manriquez F, Clarke G, Collins LM, Lévesque M, Wyatt SL, Sullivan AM, O'Keeffe GW. Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease. Brain 2021;144:e14. [PMID: 33253375 DOI: 10.1093/brain/awaa367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]

For:

Goulding SR, Concannon RM, Morales-Prieto N, Villalobos-Manriquez F, Clarke G, Collins LM, Lévesque M, Wyatt SL, Sullivan AM, O'Keeffe GW. Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease. Brain 2021;144:e14. [PMID: 33253375 DOI: 10.1093/brain/awaa367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]

Number	Citing Articles
1	Er S, Airavaara M. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease. Biochem Soc Trans 2023;51:245-57. [PMID: 36794783 DOI: 10.1042/BST20220770] [Reference Citation Analysis]
2	Cui C, Han Y, Li H, Yu H, Zhang B, Li G. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease. Front Cell Infect Microbiol 2022;12:887407. [PMID: 36034698 DOI: 10.3389/fcimb.2022.887407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3	Mantia K, Kostas V, Katerina M. The promise of the TGF-β superfamily as a therapeutic target for Parkinson's disease. Neurobiol Dis 2022;:105805. [PMID: 35764291 DOI: 10.1016/j.nbd.2022.105805] [Reference Citation Analysis]
4	Mazzocchi M, Goulding SR, Morales-Prieto N, Foley T, Collins LM, Sullivan AM, O'Keeffe GW. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease. Brain Behav Immun 2022;102:151-60. [PMID: 35217173 DOI: 10.1016/j.bbi.2022.02.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5	Whone A. Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease. Brain 2021;144:e16. [PMID: 33257974 DOI: 10.1093/brain/awaa369] [Reference Citation Analysis]